KAITLYN LANDIS: Open Payments
NPI 1396412391 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,733 in 129 payments from 25 companies in 2025. Trend: 2023 $1,191 · 2024 $2,649 · 2025 $3,733
Food & beverage: $3,688Education: $45
| Company | Payments | Amount |
|---|---|---|
| CeQur Corporation | 1 | $525 |
| Insulet Corporation | 15 | $366 |
| Amgen Inc. | 15 | $355 |
| Dexcom, Inc. | 15 | $311 |
| Novo Nordisk Inc | 11 | $307 |
| Xeris Pharmaceuticals, Inc. | 10 | $260 |
| Sequel Med Tech, LLC | 4 | $237 |
| Lilly USA, LLC | 13 | $233 |
| BETA BIONICS, INC. | 5 | $182 |
| Ascendis Pharma Endocrinology Inc | 5 | $180 |
Products named: CeQur Simplicity, Omnipod, Dexcom G6 Transmitter, REPATHA, TWIIST, Ozempic, iLet Bionic Pancreas, Yorvipath.
Industry payments across TN — which companies pay providers there.
